Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes. / Fosbøl, Emil L.; Rørth, Rasmus; Leicht, Birgitte Pernille; Schou, Morten; Maurer, Mathew S.; Kristensen, Søren Lund; Kober, Lars; Gustafsson, Finn.

In: Journal of the American College of Cardiology, Vol. 74, No. 1, 07.2019, p. 15-23.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Fosbøl, EL, Rørth, R, Leicht, BP, Schou, M, Maurer, MS, Kristensen, SL, Kober, L & Gustafsson, F 2019, 'Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes', Journal of the American College of Cardiology, vol. 74, no. 1, pp. 15-23. https://doi.org/10.1016/j.jacc.2019.04.054

APA

Fosbøl, E. L., Rørth, R., Leicht, B. P., Schou, M., Maurer, M. S., Kristensen, S. L., Kober, L., & Gustafsson, F. (2019). Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes. Journal of the American College of Cardiology, 74(1), 15-23. https://doi.org/10.1016/j.jacc.2019.04.054

Vancouver

Fosbøl EL, Rørth R, Leicht BP, Schou M, Maurer MS, Kristensen SL et al. Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes. Journal of the American College of Cardiology. 2019 Jul;74(1):15-23. https://doi.org/10.1016/j.jacc.2019.04.054

Author

Fosbøl, Emil L. ; Rørth, Rasmus ; Leicht, Birgitte Pernille ; Schou, Morten ; Maurer, Mathew S. ; Kristensen, Søren Lund ; Kober, Lars ; Gustafsson, Finn. / Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes. In: Journal of the American College of Cardiology. 2019 ; Vol. 74, No. 1. pp. 15-23.

Bibtex

@article{0f3035350b594ad79d0be0fed78325cb,
title = "Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes",
abstract = "Background: Recent studies have suggested that transthyretin amyloidosis (ATTR) is a more common cause of heart failure (HF) than previously appreciated, and novel treatments for amyloidosis are emerging. About one-half of patients with ATTR cardiac amyloidosis have a history of carpal tunnel syndrome (CTS). Objectives: This study examined the risk of amyloidosis, HF, and other adverse cardiovascular outcomes associated with CTS relative to control subjects without CTS. Methods: Using Danish nationwide registries from 1996 to 2012, 56,032 patients were identified who underwent surgical treatment for CTS, and they were compared with a sex- and age-matched cohort (ratio 1:1) from the general population to examine their risk of amyloidosis, HF, and other adverse cardiovascular outcomes. Cumulative incidence curves and Cox proportional hazard models were used to assess differences. Results: As expected, CTS was associated with a future diagnosis of amyloidosis (hazard ratio: 12.12 [95% confidence interval: 4.37 to 33.60]). CTS was associated with a higher incidence of HF, and this held true in the adjusted analysis yielding a hazard ratio of 1.54 (95% confidence interval: 1.45 to 1.64). No significant interaction with sex was found (p = 0.5). Risk of other adverse outcomes was also associated with CTS (p < 0.0001 for atrial fibrillation, atrioventricular heart block, and pacemaker implantation). Conclusions: Patients who undergo surgical treatment for CTS are associated with a higher risk of amyloidosis and HF relative to matched control subjects from the general population. Other cardiovascular outcomes were also increased with CTS.",
keywords = "amyloidosis, carpal tunnel syndrome, heart failure",
author = "Fosb{\o}l, {Emil L.} and Rasmus R{\o}rth and Leicht, {Birgitte Pernille} and Morten Schou and Maurer, {Mathew S.} and Kristensen, {S{\o}ren Lund} and Lars Kober and Finn Gustafsson",
year = "2019",
month = jul,
doi = "10.1016/j.jacc.2019.04.054",
language = "English",
volume = "74",
pages = "15--23",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier",
number = "1",

}

RIS

TY - JOUR

T1 - Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes

AU - Fosbøl, Emil L.

AU - Rørth, Rasmus

AU - Leicht, Birgitte Pernille

AU - Schou, Morten

AU - Maurer, Mathew S.

AU - Kristensen, Søren Lund

AU - Kober, Lars

AU - Gustafsson, Finn

PY - 2019/7

Y1 - 2019/7

N2 - Background: Recent studies have suggested that transthyretin amyloidosis (ATTR) is a more common cause of heart failure (HF) than previously appreciated, and novel treatments for amyloidosis are emerging. About one-half of patients with ATTR cardiac amyloidosis have a history of carpal tunnel syndrome (CTS). Objectives: This study examined the risk of amyloidosis, HF, and other adverse cardiovascular outcomes associated with CTS relative to control subjects without CTS. Methods: Using Danish nationwide registries from 1996 to 2012, 56,032 patients were identified who underwent surgical treatment for CTS, and they were compared with a sex- and age-matched cohort (ratio 1:1) from the general population to examine their risk of amyloidosis, HF, and other adverse cardiovascular outcomes. Cumulative incidence curves and Cox proportional hazard models were used to assess differences. Results: As expected, CTS was associated with a future diagnosis of amyloidosis (hazard ratio: 12.12 [95% confidence interval: 4.37 to 33.60]). CTS was associated with a higher incidence of HF, and this held true in the adjusted analysis yielding a hazard ratio of 1.54 (95% confidence interval: 1.45 to 1.64). No significant interaction with sex was found (p = 0.5). Risk of other adverse outcomes was also associated with CTS (p < 0.0001 for atrial fibrillation, atrioventricular heart block, and pacemaker implantation). Conclusions: Patients who undergo surgical treatment for CTS are associated with a higher risk of amyloidosis and HF relative to matched control subjects from the general population. Other cardiovascular outcomes were also increased with CTS.

AB - Background: Recent studies have suggested that transthyretin amyloidosis (ATTR) is a more common cause of heart failure (HF) than previously appreciated, and novel treatments for amyloidosis are emerging. About one-half of patients with ATTR cardiac amyloidosis have a history of carpal tunnel syndrome (CTS). Objectives: This study examined the risk of amyloidosis, HF, and other adverse cardiovascular outcomes associated with CTS relative to control subjects without CTS. Methods: Using Danish nationwide registries from 1996 to 2012, 56,032 patients were identified who underwent surgical treatment for CTS, and they were compared with a sex- and age-matched cohort (ratio 1:1) from the general population to examine their risk of amyloidosis, HF, and other adverse cardiovascular outcomes. Cumulative incidence curves and Cox proportional hazard models were used to assess differences. Results: As expected, CTS was associated with a future diagnosis of amyloidosis (hazard ratio: 12.12 [95% confidence interval: 4.37 to 33.60]). CTS was associated with a higher incidence of HF, and this held true in the adjusted analysis yielding a hazard ratio of 1.54 (95% confidence interval: 1.45 to 1.64). No significant interaction with sex was found (p = 0.5). Risk of other adverse outcomes was also associated with CTS (p < 0.0001 for atrial fibrillation, atrioventricular heart block, and pacemaker implantation). Conclusions: Patients who undergo surgical treatment for CTS are associated with a higher risk of amyloidosis and HF relative to matched control subjects from the general population. Other cardiovascular outcomes were also increased with CTS.

KW - amyloidosis

KW - carpal tunnel syndrome

KW - heart failure

UR - http://www.scopus.com/inward/record.url?scp=85067802615&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2019.04.054

DO - 10.1016/j.jacc.2019.04.054

M3 - Journal article

C2 - 31272537

AN - SCOPUS:85067802615

VL - 74

SP - 15

EP - 23

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 1

ER -

ID: 240199747